Cargando…
Mesenchymal stromal cells for the treatment of Alzheimer’s disease: Strategies and limitations
Alzheimer’s disease (AD) is a major cause of age-related dementia and is characterized by progressive brain damage that gradually destroys memory and the ability to learn, which ultimately leads to the decline of a patient’s ability to perform daily activities. Although some of the pharmacological t...
Autores principales: | Regmi, Shobha, Liu, Daniel Dan, Shen, Michelle, Kevadiya, Bhavesh D., Ganguly, Abantika, Primavera, Rosita, Chetty, Shashank, Yarani, Reza, Thakor, Avnesh S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584646/ https://www.ncbi.nlm.nih.gov/pubmed/36277497 http://dx.doi.org/10.3389/fnmol.2022.1011225 |
Ejemplares similares
-
Umbilical cord mesenchymal stromal cells—from bench to bedside
por: Chetty, Shashank, et al.
Publicado: (2022) -
Integrated transcriptome-proteome analyses of human stem cells reveal source-dependent differences in their regenerative signature
por: Ganguly, Abantika, et al.
Publicado: (2022) -
β Cell and Autophagy: What Do We Know?
por: Mohammadi-Motlagh, Hamid-Reza, et al.
Publicado: (2023) -
Emerging Nano- and Micro-Technologies Used in the Treatment of Type-1 Diabetes
por: Primavera, Rosita, et al.
Publicado: (2020) -
Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement
por: Ullah, Mujib, et al.
Publicado: (2019)